# Inhaled BUDESONIDE/FORMOTEROL in Bronchiolitis Obliterans Following Stem Cell Transplantation

> **NCT01560689** · PHASE2 · COMPLETED · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 32 (actual)

## Conditions studied

- Bronchiolitis Obliterans
- Allogeneic Stem Cell Transplantation

## Interventions

- **DRUG:** Budesonide/formoterol
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01560689
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-06
- **Primary completion:** 2012-07
- **Final completion:** 2012-07
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2012-09-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01560689

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01560689, "Inhaled BUDESONIDE/FORMOTEROL in Bronchiolitis Obliterans Following Stem Cell Transplantation". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01560689. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*